A 72-year-old with symptomatic lower extremity peripheral artery disease underwent endovascular revascularization 2 months ago. He is on aspirin 81 mg daily and high-intensity statin. Which antithrombotic regimen reduces major adverse limb and cardiovascular events per current guidance?